| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Commentary on cardiovascular risk
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S46-
1 p.
|
artikel
|
| 2 |
Commentary on conversion strategies
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S59-
1 p.
|
artikel
|
| 3 |
Commentary on novel immunosuppressive strategies: steroid avoidance
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S61-
1 p.
|
artikel
|
| 4 |
Commentary on optimal maintenance immunosuppression: interpreting registry data
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S54-
1 p.
|
artikel
|
| 5 |
Commentary on pretransplantation: identifying risk factors
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S36-
1 p.
|
artikel
|
| 6 |
Commentary on pretransplantation: removing immunologic barriers
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S32-
1 p.
|
artikel
|
| 7 |
Commentary on reducing complications after transplantation: posttransplant diabetes mellitus
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S42-
1 p.
|
artikel
|
| 8 |
Commentary on reducing complications after transplantation: the significance of renal allograft function
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S40-
1 p.
|
artikel
|
| 9 |
Commentary on reducing infectious risks: polyoma (BK) virus
|
Gason, Robert
|
|
2003
|
|
4S2 |
p. S49-
1 p.
|
artikel
|
| 10 |
Commentary on tacrolimus-sirolimus
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S65-
1 p.
|
artikel
|
| 11 |
Conclusion
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S70-
1 p.
|
artikel
|
| 12 |
Contents
|
|
|
2003
|
|
4S2 |
p. ii-
1 p.
|
artikel
|
| 13 |
Introduction
|
Gaston, Robert
|
|
2003
|
|
4S2 |
p. S31-
1 p.
|
artikel
|
| 14 |
Masthead
|
|
|
2003
|
|
4S2 |
p. i-
1 p.
|
artikel
|
| 15 |
Study 1: a fresh look at early serum creatinine at one, two, and three years as a surrogate marker for long-term outcomes in renal immunosuppression
|
McEwan, Phil C.
|
|
2003
|
|
4S2 |
p. S41-
1 p.
|
artikel
|
| 16 |
Study 1: an open-label pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in renal allograft recipients on a regimen of maintenance therapy with moderate renal insufficiency
|
Peddi, V.Ram
|
|
2003
|
|
4S2 |
p. S60-
1 p.
|
artikel
|
| 17 |
Study 1: a prospective, randomized, double-blind, multicenter trial of early (7-day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy under tacrolimus and mycophenolate mofetil therapy with antibody induction
|
Woodle, E.S.
|
|
2003
|
|
4S2 |
p. S62-S63
2 p.
|
artikel
|
| 18 |
Study 1: a prospective, randomized study of cyclosporine-mycophenolate mofetil versus tacrolimus-sirolimus with rapid discontinuation of prednisone
|
Kandaswamy, Raja
|
|
2003
|
|
4S2 |
p. S43-S44
2 p.
|
artikel
|
| 19 |
Study 2: a randomized, single-center, long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (neoral) and sirolimus after renal transplantation: 1-year interim analysis
|
Ciancio, Gaetano
|
|
2003
|
|
4S2 |
p. S68-S69
2 p.
|
artikel
|
| 20 |
Study 2: BK polyomavirus nephritis and acute rejection tend to affect distinct groups of renal allograft recipients: a role for gender, race, and tacrolimus levels
|
Rocha, Paulo N.
|
|
2003
|
|
4S2 |
p. S51-
1 p.
|
artikel
|
| 21 |
Study 1: characterization of acute rejection episodes after pre-emptive plasmapheresis and cytomegalovirus hyperimmune globulin to abrogate a positive crossmatch and allow live donor renal transplantation
|
Sonnenday, Christopher J.
|
|
2003
|
|
4S2 |
p. S33-
1 p.
|
artikel
|
| 22 |
Study 2: comparison of tacrolimus and sirolimus combination with tacrolimus and mycophenolate mofetil in kidney transplant recipients with steroid avoidance
|
Kumar, Aparna
|
|
2003
|
|
4S2 |
p. S45-
1 p.
|
artikel
|
| 23 |
Study 3: early steroid cessation-avoidance regimens are associated with a lower incidence of polyomavirus nephropathy compared with steroid-based immunosuppression in kidney transplant recipients
|
Trofe, J.
|
|
2003
|
|
4S2 |
p. S52-S53
2 p.
|
artikel
|
| 24 |
Study 1: effect of type of immunosuppression reduction in patients with BK allograft nephropathy
|
Ramos, Emilio
|
|
2003
|
|
4S2 |
p. S50-
1 p.
|
artikel
|
| 25 |
Study 2: evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the National Institutes of Health IG02 trial
|
Jordan, Stanley C.
|
|
2003
|
|
4S2 |
p. S34-
1 p.
|
artikel
|
| 26 |
Study 1: graft survival after living donor renal transplantation: a comparison between tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids
|
Bunnapradist, Suphamai
|
|
2003
|
|
4S2 |
p. S55-S56
2 p.
|
artikel
|
| 27 |
Study 1: long-term cardiovascular risk after kidney transplantation
|
First, M.R.
|
|
2003
|
|
4S2 |
p. S47-
1 p.
|
artikel
|
| 28 |
Study 1: one-year results of the first prospective, randomized, multicenter kidney transplant study comparing tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil combination therapy
|
Mendez, R.
|
|
2003
|
|
4S2 |
p. S66-S67
2 p.
|
artikel
|
| 29 |
Study 3: outcome of ABO-incompatible kidney transplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroids
|
Tanabe, Kazunari
|
|
2003
|
|
4S2 |
p. S35-
1 p.
|
artikel
|
| 30 |
Study 3: posttransplant diabetes mellitus: evidence for glucose intolerance and insulin resistance existing before transplantation
|
Pesavento, Todd E.
|
|
2003
|
|
4S2 |
p. S39-
1 p.
|
artikel
|
| 31 |
Study 2: relationship between pretransplant obesity and posttransplant cardiovascular events, diabetes mellitus, and graft and patient survival in renal transplant recipients
|
de Mattos, Angelo M.
|
|
2003
|
|
4S2 |
p. S38-
1 p.
|
artikel
|
| 32 |
Study 2: short-term benefit of tacrolimus versus cyclosporine therapy after renal transplantation: an analysis of United Network for Organ Sharing/Organ Procurement and Transplantation Network database
|
Bresnahan, Barbara A.
|
|
2003
|
|
4S2 |
p. S57-
1 p.
|
artikel
|
| 33 |
Study 2: steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus: analysis of renal function beyond 1 year
|
Hricik, Donald E.
|
|
2003
|
|
4S2 |
p. S64-
1 p.
|
artikel
|
| 34 |
Study 2: tacrolimus as secondary intervention versus continuation of cyclosporine in patients at risk for chronic renal allograft failure results in improved renal function, decreased cardiovascular risk, and no increased risk for diabetes
|
Waid, Thomas H.
|
|
2003
|
|
4S2 |
p. S48-
1 p.
|
artikel
|
| 35 |
Study 3: the effect of maintenance immunosuppression medication on the change in kidney allograft function
|
Gill, John S.
|
|
2003
|
|
4S2 |
p. S58-
1 p.
|
artikel
|
| 36 |
Study 1: unexpected high incidence of coronary artery disease and abnormal platelet reactivity in long-term pediatric kidney transplant recipients
|
Kim, Dean Y.
|
|
2003
|
|
4S2 |
p. S37-
1 p.
|
artikel
|
Tijdschrift beschrijving